Completed Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors NCT01967537 Conditions Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +16 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details
Completed 17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease NCT00088374 Conditions Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +26 more Locations National Cancer Institute, National Institutes of Health — Bethesda, Maryland, United States View Trial Details
Completed EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome NCT00056199 Conditions Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +27 more Locations National Eye Institute (NEI) — Bethesda, Maryland, United States View Trial Details
